Interesting anecdote from MD Anderson.
18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination [1]
-Patrick
[1] pubmed.ncbi.nlm.nih.gov/341...
Clin Nucl Med
. 2021 Jun 28. doi: 10.1097/RLU.0000000000003844. Online ahead of print.
18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination
Franklin C Wong 1 , Lucia Martiniova, Avantika Masrani, Gregory C Ravizzini
Affiliations collapse
Affiliation
1 From the University of Texas MD Anderson Cancer Center, Houston, TX.
PMID: 34183501 DOI: 10.1097/RLU.0000000000003844
Abstract
A 74-year-old man presenting with biochemical recurrent prostate cancer 9 months after robotic-assisted radical prostatectomy and pelvic lymphadenectomy underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. Serum prostate-specific antigen was 0.7 ng/mL at the time of imaging. Images demonstrated foci of abnormal increased 18F-fluciclovine uptake corresponding to prominent round lymph nodes in the left axilla, some of which with fatty hila. Due to recent mRNA COVID-19 vaccination in the ipsilateral arm and the low likelihood of nodal metastases to the axilla from prostate cancer in this patient, the lymph nodes were considered to be benign, reactive to the vaccine.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.